Abstract P114 – Table 1. Demographical and clinical characteristics of PHI and C‐Naïve patients.
Characteristic	PHI (N = 11)	Chronic naive (N = 10)	p‐value
Age at diagnosis [years], median (IQR)	41 (29 to 45)	42 (34 to 51)	0.3408
Male, sex (%)	11 (100)	8 (80)	0.2143
Ethnicity, n (%)			0.3108
Caucasian	10 (91)	7 (70)
Other	1 (9)	3 (30)
Epidemiology, n (%)			0.5865
MSM	10 (91)	8 (80)
Heterosexual/unknown	1 (9)	2 (20)
HBV/HCV coinfection, n (%)	3 (27)	3 (30)	1
Nadir CD4 [cell/mmc], median (IQR)	538 (493 to 609)	147 (12 to 279)	0.0006
CD4 count at colonoscopy [cell/mmc], median (IQR)	538 (446 to 651)	176 (94 to 279)	0.0008
CD4% at colonoscopy, median (IQR)	25 (14 to 28)	17 (10 to 18)	0.1295
CD8 count at colonoscopy [cell/mmc], median (IQR)	1332 (826 to 1752)	688 (248 to 925)	0.0183
CD8% at colonoscopy, median (IQR)	56 (49 to 72)	58 (49 to 66)	0.5256
CD4/CD8 ratio at colonoscopy, median (IQR)	0.50 (0.19 to 0.57)	0.26 (0.15 to 0.32)	0.1693
HIV‐RNA at colonoscopy [log10 copies/mL], median (IQR)	5.58 (5.16 to 5.92)	5.13 (4.80 to 5.42)	0.0528
Fiebig stage, n (%)			/
I to III	2 (18)	/
IV to VI	9 (82)	/
CDC stage, n (%)			0.0560
A1 to A3	9 (82)	3 (30)
B1 to B3	1 (9)	3 (30)
C1 to C3	1 (9)	4 (40)
First HAART regimen, n (%)			/
INSTI‐based	6 (55)	/
PI‐based	3 (27)	/
Mega‐HAART (INSTI+PI)	2 (18)	/